New Gene Therapy Offers Hope for Mesothelioma Patients
News Summary Genprex, Inc. has announced a significant partnership with NYU Langone Health to develop Reqorsa®, a groundbreaking gene therapy for malignant pleural mesothelioma. This therapy, which shows promise in preclinical trials by halting cancer cell growth and increasing cell death, aims to address the dire prognosis faced by mesothelioma patients. With the formation of […]
Portage Biotech Inc. Rockets Amid Mesothelioma Breakthrough
News Summary Portage Biotech Inc. shares surged over 27% following the announcement of promising preclinical results for a novel mesothelioma treatment, PORT-7. Portage Biotech Inc. Rockets Amid Mesothelioma Breakthrough In a surprising twist in the world of oncology, Portage Biotech Inc. (PRTG) shares experienced a remarkable surge of over 27% on Monday, marking their best […]
Major Medical Breakthrough for Mesothelioma Patients in Canada
News Summary Health Canada approves KEYTRUDA® as a first-line treatment for malignant pleural mesothelioma, offering hope for improved patient outcomes. Major Medical Breakthrough for Mesothelioma Patients in Canada In an exciting development for the treatment of malignant pleural mesothelioma (MPM), Health Canada has granted approval for KEYTRUDA® (pembrolizumab), an innovative anti-PD-1 therapy from Merck, also […]
Breakthrough in Mesothelioma Treatment as Genprex, Inc. Partners with NYU Langone Health
News Summary Genprex, Inc. announces a partnership with NYU Langone Health for mesothelioma treatment using Reqorsa® Gene Therapy, targeting the TUSC2 gene. Breakthrough in Mesothelioma Treatment as Genprex, Inc. Partners with NYU Langone Health In a pivotal move for cancer therapy, Genprex, Inc. (GNPX), a clinical-stage gene therapy company, has recently made waves by announcing […]
Genprex Gains Momentum in Mesothelioma Treatment with Exclusive Patent License
News Summary Genprex signs exclusive patent license with NYU Langone for Reqorsa® Gene Therapy aiming to treat mesothelioma, showing promising preclinical results. Genprex Gains Momentum in Mesothelioma Treatment with Exclusive Patent License Genprex, Inc. (NASDAQ: GNPX), a clinical-stage gene therapy company based in Austin, Texas, has made headlines recently by signing an exclusive patent license […]
Genprex Partners with NYU Langone in Groundbreaking Mesothelioma Therapy Development
News Summary Genprex, Inc. partners with NYU Langone to advance its gene therapy Reqorsa, targeting malignant pleural mesothelioma, aiming to improve patient outcomes. Genprex Partners with NYU Langone in Groundbreaking Mesothelioma Therapy Development In a significant advancement for cancer treatment, Genprex, Inc. (NASDAQ: GNPX) has entered into an exclusive patent license agreement with NYU Langone […]
Portage Biotech Unveils Groundbreaking Preclinical Results for Mesothelioma Treatment
News Summary Portage Biotech announces promising preclinical results for PORT-7, a treatment for mesothelioma, demonstrating exceptional efficacy in combination with anti-PD1 antibody. Portage Biotech Unveils Groundbreaking Preclinical Results for Mesothelioma Treatment Significant Advances in Cancer Therapeutics In a groundbreaking development, Portage Biotech Inc. has announced confirmatory preclinical efficacy results for its promising treatment candidate, PORT-7. […]
Portage Biotech Inc. Makes Waves with Promising Mesothelioma Treatment
News Summary Portage Biotech has announced breakthrough developments in mesothelioma treatment with PORT-7, a game-changing drug candidate set to enter human trials. Portage Biotech Inc. Makes Waves with Promising Mesothelioma Treatment On April 28, 2025, Portage Biotech Inc., trading under the symbol PRTG, unveiled groundbreaking developments in their cancer treatment pipeline, particularly aimed at mesothelioma, […]
The Future of Mesothelioma Treatment: A New Gene Therapy Breakthrough
News Summary Genprex, Inc. has announced a new gene therapy treatment for mesothelioma, expanding its portfolio with an exclusive agreement for Reqorsa® Gene Therapy. The Future of Mesothelioma Treatment: A New Gene Therapy Breakthrough The fight against mesothelioma, a devastating cancer primarily linked to asbestos exposure, is seeing promising developments thanks to Genprex, Inc., a […]
A Dark Chapter in Australia’s History: The Demolition of Wittenoom
News Summary The demolition of Wittenoom, a former mining hub in Western Australia, has begun due to severe asbestos contamination. The extreme health risks, including over 2,000 deaths from asbestos-related diseases, highlight the tragic legacy of industrial negligence. While the town is being dismantled, concerns about accountability and cleanup responsibilities remain, as the state government […]